Latest news with #CuriosityStream
New York Post
3 days ago
- Entertainment
- New York Post
Save $200 on lifetime access to thousands of documentaries
Discover startups, services, products and more from our partner StackCommerce. New York Post edits this content, and may be compensated and/or receive an affiliate commission if you buy through our links. TL;DR: Get lifetime access to thousands of documentaries on Curiosity Stream for just $199.99 (MSRP: $399.99). Most of us know the feeling of having just finished a season finale, and now you're stuck waiting a year for the next one (if it ever comes back). What if you could swap that limbo for something actually binge-worthy—and brain-boosting? That's why Curiosity Stream is an entertainment game changer. This streaming service is packed with outstanding documentaries, original series, and gripping storytelling—all for a one-time payment of $199.99 (that's 50 percent off the $399.99 MSRP). Advertisement Founded by Discovery Channel's own John Hendricks, Curiosity Stream is all about the good stuff: science, history, technology, nature, space, and more. It's basically the antidote to everything mind-numbing in your Continue Watching list. And the best part is that it's a lifetime subscription. No monthly fees. No cancellations to worry about. Just pure, unfiltered facts and visuals, from the story of human evolution to the future of AI. Whether you're streaming on the subway, casting from your couch in Queens, or watching in airplane mode en route to Iceland, you've got offline access, too. Not sure where to start? Try Engineering the Future, Planet of Treasures, or The History of Home. And with new content added weekly, your curiosity will never hit a dead end. Whether you're a casual doc fan or a full-on knowledge junkie, this deal lets you turn downtime into discovery for life. Go ahead, give your brain something to binge. Get lifetime access to Curiosity Stream for the one-time payment of $199.99 (MSRP: $399.99) for a limited time. StackSocial prices subject to change.
Business Wire
6 days ago
- Business
- Business Wire
Curiosity Stream Expands Global Prime Video Partnership with Launch as an Add-On Subscription in Australia and New Zealand
SILVER SPRING, Md.--(BUSINESS WIRE)--Curiosity Inc. (NASDAQ: CURI), a leading global factual media company, today announced the launch of its flagship streaming service, Curiosity Stream, as an add-on subscription on Prime Video in Australia and New Zealand. This marks the latest milestone in the company's strategic expansion with Prime Video, which already includes channel distribution in the U.S., the U.K., India, the Netherlands, Sweden and Finland. Curiosity Stream's rollout in Australia and New Zealand positions the service for deeper regional expansion at a time when audiences are increasingly seeking out high-quality, non-fiction storytelling. Prime Video members in both countries can now seamlessly subscribe to Curiosity Stream directly through Prime Video, gaining access to a robust library of thousands of films, series, and specials exploring science, nature, history, technology, society, and more. 'We've seen strong traction with Prime Video add-on subscriptions across multiple key territories,' said Jay Sodha, VP of Business Development and Partnerships for Curiosity. 'Expanding into Australia and New Zealand is a natural extension of our international strategy. Partner-direct distribution remains a critical pillar for reaching new audiences at scale and delivering frictionless access to our brand of smart, engaging content.' This continued expansion with Prime Video underscores Curiosity's commitment to global, platform-integrated distribution, capitalizing on the discoverability and billing simplicity that Prime Video Channels offers. Curiosity Stream's availability as a Prime Video add-on subscription joins its presence across a growing global footprint that includes direct-to-consumer apps, smart TVs, connected devices, MVPD partners, and AVOD/FAST offerings such as Curiosity Now. The company continues to invest in original programming, localized expansion, and strategic partnerships that reinforce its leadership position in the factual entertainment space. About CuriosityStream Inc. CuriosityStream Inc. is the entertainment brand for people who want to know more. The global media company is home to award-winning original and curated factual films, shows, and series covering science, nature, history, technology, society, and lifestyle. With millions of subscribers worldwide and thousands of titles, the company operates the flagship Curiosity Stream SVOD service, available in more than 175 countries worldwide; Curiosity Channel, the linear television channel available via global distribution partners; Curiosity University, featuring talks from the best professors at the world's most renowned universities as well as courses, short and long-form videos, and podcasts; Curiosity Now, Curiosity Explora, and other free, ad-supported channels; Curiosity Audio Network, with original content and podcasts; and Curiosity Studios, which oversees original programming. Curiosity Inc. is a wholly owned subsidiary of CuriosityStream Inc. (Nasdaq: CURI). For more information, visit
Business Wire
6 days ago
- Business
- Business Wire
Curiosity Stream Expands Global Prime Video Partnership with Launch as an Add-On Subscription
SILVER SPRING, Md.--(BUSINESS WIRE)-- Curiosity Inc. (NASDAQ: CURI), a leading global factual media company, today announced the launch of its flagship streaming service, Curiosity Stream, as an add-on subscription on Prime Video in Australia and New Zealand. This marks the latest milestone in the company's strategic expansion with Prime Video, which already includes channel distribution in the U.S., the U.K., India, the Netherlands, Sweden and Finland. Curiosity Stream's rollout in Australia and New Zealand positions the service for deeper regional expansion at a time when audiences are increasingly seeking out high-quality, non-fiction storytelling. Prime Video members in both countries can now seamlessly subscribe to Curiosity Stream directly through Prime Video, gaining access to a robust library of thousands of films, series, and specials exploring science, nature, history, technology, society, and more. 'We've seen strong traction with Prime Video add-on subscriptions across multiple key territories,' said Jay Sodha, VP of Business Development and Partnerships for Curiosity. 'Expanding into Australia and New Zealand is a natural extension of our international strategy. Partner-direct distribution remains a critical pillar for reaching new audiences at scale and delivering frictionless access to our brand of smart, engaging content.' This continued expansion with Prime Video underscores Curiosity's commitment to global, platform-integrated distribution, capitalizing on the discoverability and billing simplicity that Prime Video Channels offers. Curiosity Stream's availability as a Prime Video add-on subscription joins its presence across a growing global footprint that includes direct-to-consumer apps, smart TVs, connected devices, MVPD partners, and AVOD/FAST offerings such as Curiosity Now. The company continues to invest in original programming, localized expansion, and strategic partnerships that reinforce its leadership position in the factual entertainment space. About CuriosityStream Inc. CuriosityStream Inc. is the entertainment brand for people who want to know more. The global media company is home to award-winning original and curated factual films, shows, and series covering science, nature, history, technology, society, and lifestyle. With millions of subscribers worldwide and thousands of titles, the company operates the flagship Curiosity Stream SVOD service, available in more than 175 countries worldwide; Curiosity Channel, the linear television channel available via global distribution partners; Curiosity University, featuring talks from the best professors at the world's most renowned universities as well as courses, short and long-form videos, and podcasts; Curiosity Now, Curiosity Explora, and other free, ad-supported channels; Curiosity Audio Network, with original content and podcasts; and Curiosity Studios, which oversees original programming. Curiosity Inc. is a wholly owned subsidiary of CuriosityStream Inc. (Nasdaq: CURI). For more information, visit
Yahoo
02-08-2025
- Business
- Yahoo
3 Penny Stocks With Market Caps Larger Than $10M To Watch
As major U.S. indexes continue their upward trajectory, buoyed by strong corporate earnings and resilient economic data, investors are exploring various avenues for potential growth. Penny stocks, though an older term in the investment lexicon, remain relevant as a category that encompasses smaller or newer companies with lower price points. When these stocks are backed by robust financials and solid fundamentals, they can present unique opportunities for growth that might be overlooked in more traditional investment sectors. Top 10 Penny Stocks In The United States Name Share Price Market Cap Financial Health Rating Waterdrop (WDH) $1.66 $640.14M ★★★★★★ CuriosityStream (CURI) $4.59 $259.69M ★★★★★★ WM Technology (MAPS) $0.9048 $157.25M ★★★★★★ Tuniu (TOUR) $0.9326 $96.34M ★★★★★★ Cardno (COLD.F) $0.1701 $6.64M ★★★★★★ BAB (BABB) $0.8906 $6.51M ★★★★★★ Lifetime Brands (LCUT) $4.44 $103.55M ★★★★★☆ Resources Connection (RGP) $4.98 $169.03M ★★★★★★ TETRA Technologies (TTI) $3.91 $508.34M ★★★★★★ Tandy Leather Factory (TLF) $3.45 $30.22M ★★★★★★ Click here to see the full list of 413 stocks from our US Penny Stocks screener. Here's a peek at a few of the choices from the screener. MediciNova Simply Wall St Financial Health Rating: ★★★★★★ Overview: MediciNova, Inc. is a biopharmaceutical company that develops novel small molecule therapeutics for serious diseases with unmet medical needs in the United States, with a market cap of $65.23 million. Operations: MediciNova, Inc. currently does not report any revenue segments. Market Cap: $65.23M MediciNova, Inc., a pre-revenue biopharmaceutical company with a market cap of US$65.23 million, is advancing its clinical pipeline despite financial challenges. The company remains debt-free and has sufficient cash runway for over three years. Recent updates highlight nearing completion of key trials for MN-166 and MN-001, targeting serious diseases like ALS and fatty liver disease. Although unprofitable with net losses reported at US$2.86 million in Q1 2025, MediciNova's seasoned management and board offer stability as it navigates the volatile penny stock landscape while holding Orphan Drug Designations for several treatments from the FDA and EU EMA. Click here and access our complete financial health analysis report to understand the dynamics of MediciNova. Understand MediciNova's earnings outlook by examining our growth report. Vasta Platform Simply Wall St Financial Health Rating: ★★★★★★ Overview: Vasta Platform Limited offers educational printed and digital solutions to private schools in Brazil's K-12 sector, with a market cap of $330.47 million. Operations: The company generates revenue through its Educational Services segment, specifically in Education & Training Services, amounting to R$1.64 billion. Market Cap: $330.47M Vasta Platform Limited, with a market cap of $330.47 million, operates in Brazil's K-12 educational sector and has recently become profitable, though its earnings are forecast to decline by an average of 55.2% annually over the next three years. Trading at a value below its estimated fair value and compared to peers, Vasta's financial health is supported by satisfactory debt levels and interest coverage. However, recent results show a net loss of R$3.27 million for Q1 2025 against revenue declines from the previous year. Management experience remains unclear while one-off gains have impacted past earnings quality. Unlock comprehensive insights into our analysis of Vasta Platform stock in this financial health report. Gain insights into Vasta Platform's future direction by reviewing our growth report. Hugoton Royalty Trust Simply Wall St Financial Health Rating: ★★★★★★ Overview: Hugoton Royalty Trust operates as an express trust in the United States with a market cap of $14.40 million. Operations: The trust's revenue is derived from its Oil & Gas - Exploration & Production segment, totaling $0.01 million. Market Cap: $14.4M Hugoton Royalty Trust, with a market cap of US$14.40 million, operates in the oil and gas sector but remains pre-revenue with earnings for Q1 2025 at just US$2,407. The trust is unprofitable yet has managed to reduce losses over five years by 28.4% annually. Despite its debt-free status and stable shareholder base without recent dilution, the stock's high volatility poses risks for investors. Recent changes include appointing Grant Thornton LLP as the new auditor after dismissing PwC and experiencing delays in SEC filings, reflecting potential operational challenges amidst an already unstable financial position. Jump into the full analysis health report here for a deeper understanding of Hugoton Royalty Trust. Understand Hugoton Royalty Trust's track record by examining our performance history report. Make It Happen Navigate through the entire inventory of 413 US Penny Stocks here. Want To Explore Some Alternatives? The end of cancer? These 25 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include MNOV VSTA and HGTX.U. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31-07-2025
- Business
- Yahoo
Exploring US High Growth Tech Stocks For Potential Portfolio Expansion
As the U.S. stock market navigates a landscape of fluctuating indices and economic indicators, investors are closely monitoring the Federal Reserve's interest rate decisions and major tech earnings reports, which have recently driven optimism despite intermittent setbacks. In this dynamic environment, identifying high growth tech stocks that align with strong corporate earnings and favorable economic data can be an effective strategy for those looking to expand their portfolios amidst evolving market conditions. Top 10 High Growth Tech Companies In The United States Name Revenue Growth Earnings Growth Growth Rating ACADIA Pharmaceuticals 10.44% 23.61% ★★★★★☆ Palantir Technologies 22.52% 30.87% ★★★★★★ Circle Internet Group 30.80% 60.66% ★★★★★★ Workday 11.38% 29.97% ★★★★★☆ Mereo BioPharma Group 51.11% 57.42% ★★★★★★ OS Therapies 38.35% 16.51% ★★★★★☆ RenovoRx 62.57% 63.11% ★★★★★☆ Vanda Pharmaceuticals 27.11% 60.56% ★★★★★☆ Gorilla Technology Group 27.85% 105.48% ★★★★★☆ Aldeyra Therapeutics 41.72% 74.79% ★★★★★☆ Click here to see the full list of 70 stocks from our US High Growth Tech and AI Stocks screener. Let's review some notable picks from our screened stocks. CuriosityStream Simply Wall St Growth Rating: ★★★★☆☆ Overview: CuriosityStream Inc. is a media and entertainment company that offers factual content across various platforms, with a market cap of $269.50 million. Operations: CuriosityStream generates revenue primarily from its Curiosity Stream segment, which brought in $54.22 million. CuriosityStream, a burgeoning name in the tech-driven entertainment sector, is making significant strides with its innovative streaming service, Curiosity University. This platform has recently expanded into European markets through Amazon Prime Video Channels in Sweden and the UK, blending academic rigor with compelling storytelling to tap into a growing demand for knowledge-rich content. Impressively, CuriosityStream's earnings are projected to surge by 110.8% annually. Moreover, the company has been actively enhancing shareholder value through strategic shelf registration filings totaling $13.77 million and declaring special dividends reflecting robust improvements in cash flow and profitability—a testament to its financial health and forward-looking management strategies. Dive into the specifics of CuriosityStream here with our thorough health report. Assess CuriosityStream's past performance with our detailed historical performance reports. Mereo BioPharma Group Simply Wall St Growth Rating: ★★★★★★ Overview: Mereo BioPharma Group plc is a biopharmaceutical company focused on developing and commercializing therapeutics for oncology and rare diseases across the UK, US, and internationally, with a market cap of $279.84 million. Operations: Mereo BioPharma Group focuses on developing therapeutics for oncology and rare diseases, with operations spanning the UK, US, and international markets. The company's revenue streams are primarily derived from its biopharmaceutical products in these specialized fields. Mereo BioPharma Group, amid a challenging landscape, is steering towards profitability with an anticipated revenue growth of 51.1% per year, significantly outpacing the US market's average of 9%. This growth trajectory is supported by promising developments in their clinical programs, notably the Phase 3 study of setrusumab for osteogenesis imperfecta. Despite a recent increase in net loss to $12.89 million from last year's $8.95 million, Mereo's strategic focus on rare genetic diseases positions it uniquely within the biotech sector. The company's R&D commitment is underscored by its ongoing investment in innovative therapies that address unmet medical needs, setting a foundation for potential future success in a highly specialized market. Unlock comprehensive insights into our analysis of Mereo BioPharma Group stock in this health report. Understand Mereo BioPharma Group's track record by examining our Past report. Vanda Pharmaceuticals Simply Wall St Growth Rating: ★★★★★☆ Overview: Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapies for high unmet medical needs globally, with a market cap of $276.99 million. Operations: Vanda Pharmaceuticals focuses on developing and commercializing therapies for unmet medical needs, generating revenue primarily from its biotechnology segment, which contributed $201.35 million. Vanda Pharmaceuticals, recently added to the Russell 2000 Defensive Index, is navigating a transformative phase with a projected annual revenue growth of 27.1%. This growth is bolstered by innovative clinical trials like the first-in-human study for VCA-894A targeting Charcot-Marie-Tooth disease, highlighting its strategic pivot towards specialized therapeutic areas. Despite a substantial net loss increase to $29.49 million in Q1 2025 from $4.15 million previously, Vanda's aggressive R&D investment reflects its commitment to addressing rare genetic disorders, potentially reshaping treatment paradigms and driving future profitability expected within three years. Click here and access our complete health analysis report to understand the dynamics of Vanda Pharmaceuticals. Evaluate Vanda Pharmaceuticals' historical performance by accessing our past performance report. Next Steps Click here to access our complete index of 70 US High Growth Tech and AI Stocks. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Ready For A Different Approach? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CURI MREO and VNDA. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
